CINECA IRIS Institutional Research Information System

FUNEL, NICCOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.229
EU - Europa 4.656
AS - Asia 4.306
SA - Sud America 553
AF - Africa 246
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.388
CA - Canada 4.773
SG - Singapore 1.326
IT - Italia 1.323
CN - Cina 1.225
PL - Polonia 1.044
HK - Hong Kong 663
SE - Svezia 554
BR - Brasile 445
VN - Vietnam 359
DE - Germania 342
BG - Bulgaria 294
GB - Regno Unito 225
FR - Francia 203
IN - India 170
TR - Turchia 141
FI - Finlandia 135
RU - Federazione Russa 132
JP - Giappone 128
AT - Austria 89
UA - Ucraina 89
CI - Costa d'Avorio 76
NL - Olanda 53
CH - Svizzera 46
SN - Senegal 43
KR - Corea 42
BD - Bangladesh 39
NG - Nigeria 33
AR - Argentina 30
BE - Belgio 29
MX - Messico 28
IQ - Iraq 26
PK - Pakistan 25
EC - Ecuador 24
IE - Irlanda 22
ES - Italia 21
MA - Marocco 21
ZA - Sudafrica 21
TW - Taiwan 18
ID - Indonesia 17
SA - Arabia Saudita 17
VE - Venezuela 17
EG - Egitto 15
TN - Tunisia 14
UZ - Uzbekistan 14
CO - Colombia 12
JO - Giordania 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 10
PH - Filippine 10
AU - Australia 9
CL - Cile 8
CR - Costa Rica 8
IL - Israele 8
MY - Malesia 8
JM - Giamaica 7
NP - Nepal 7
BJ - Benin 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
PY - Paraguay 6
TH - Thailandia 6
AZ - Azerbaigian 5
DZ - Algeria 5
EU - Europa 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
ET - Etiopia 4
IR - Iran 4
KE - Kenya 4
LU - Lussemburgo 4
OM - Oman 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LB - Libano 2
NZ - Nuova Zelanda 2
PE - Perù 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BM - Bermuda 1
Totale 22.996
Salva come PNG Salva come JPEG
Città #
Montreal 4.593
Ashburn 877
Woodbridge 837
Singapore 712
Hong Kong 657
Fairfield 538
Santa Clara 521
Chandler 513
Ann Arbor 487
Dallas 438
San Jose 430
Houston 398
Milan 330
Sofia 293
Shanghai 269
Beijing 226
Wilmington 210
Seattle 201
New York 199
Cambridge 194
Serra 180
Boardman 151
Princeton 145
Ottawa 139
Jacksonville 120
Los Angeles 114
Lawrence 110
Tokyo 105
Lauterbourg 104
Dearborn 100
Ho Chi Minh City 95
Pisa 93
Florence 87
Medford 85
London 80
Vienna 79
Abidjan 76
Izmir 76
Nanjing 73
Boulder 67
Frankfurt am Main 59
Hanoi 59
Rome 59
Des Moines 56
Helsinki 55
Munich 51
Redwood City 47
Council Bluffs 43
Buffalo 42
Dakar 42
Bern 40
Istanbul 39
San Diego 38
Redondo Beach 37
Hefei 36
Dong Ket 33
Lagos 33
Nanchang 33
Hyderabad 32
São Paulo 32
Chicago 30
Kunming 29
Washington 29
Seoul 28
Nuremberg 27
Shenyang 27
Orem 26
Bremen 25
Düsseldorf 25
Ogden 25
Brussels 24
Columbus 22
Fuzhou 22
Livorno 22
Guangzhou 21
Grafing 20
Jüchen 20
Kent 19
The Dalles 19
Warsaw 19
Lucca 17
Paris 15
Changsha 14
Denver 14
Manchester 14
Norwalk 14
Brooklyn 13
Chennai 13
Hangzhou 13
Hebei 13
Tashkent 13
Toronto 13
Jakarta 12
Jiaxing 12
Mumbai 12
Rio de Janeiro 12
San Francisco 12
Turku 12
Amsterdam 11
Atlanta 11
Totale 16.607
Salva come PNG Salva come JPEG
Nome #
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER 3.303
PANCREATIC METASTASES FROM RENAL CARCINOMA 2.567
Zebrafish embryos as avatar of patients with pancreatic cancer: preliminary results of validation a new model toward personalized medicine 313
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 270
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 232
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 226
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice. 225
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models 218
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 214
Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields 211
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 211
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 211
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 199
Robotic-assisted versus open left pancreatectomy for cystic tumours: A single-centre experience 199
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours 197
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 194
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 191
Mesenchymal stem cells and magnetic nanoparticles: in vitro studies and in vivo protocol validation for cellular homing into a target organ by magnetic fields 189
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 186
EUS-FNA wet technique for the pre-operative diagnosis of 31 solid pancreatic tumors: Pisa experience 183
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia 179
RNA-SCOPE TECHNOLOGY AND IMMUNOHISTOCHEMISTRY REVEAL LOW EXPRESSION OF MUC5AC IN METASTATIC PANCREATIC PATIENTS: EPIGENETIC PITFALLS OR A BETTER DISEASE STATUS? 176
Epigenetic expression of MUC5AC in metastatic pancreatic patients using RNA-scope technology and immunohistochemistry 176
Cellular Transfection Evidence in Pancreatic Tumor Primary Cell Cultures Through Electroporation of Green Fluorescent Protein (GFP) 175
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 175
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine 172
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 CAN IDENTIFY PATHOLOGICAL SUBTYPES OF AMPULLARY ADENOCARCINOMAS AND THEIR PROGNOSIS 171
Liver fat accumulation and isolated islets function in non-diabetic and type 2 diabetic subjects 168
Homozygosis Mutation in K-ras Oncogene in Primary Cell Culture from Pancreatic Ductal Adenocarcinoma. Characteristic of the Tumor or Adaptation in Vitro? 168
Preclinical emergence of novel lactate dehydrogenase inhibitors as potent antitumor agents in hypoxic models of pancreatic cancer: molecular mechanisms underlying their synergistic interaction with gemcitabine 168
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. 168
SINGLE INSTITUTION EXPERIENCE WITH PANCREATECTOMIES ASSOCIATED TO VASCULAR RESECTION 167
Ampullary adenocarcinomas: The immunohistochemical score of CDX2, CK7 and CK 20 identify pathological subtypes and their prognosis 167
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies 166
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. 166
A PERSONAL INVAGINATION PANCREATICOJEJUNOSTOMY TECHNIQUE AFTER PANCREATICODUODENECTOMY: DESCRIPTION, TECHNICAL DETAILS AND RESULTS 165
The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter 164
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 164
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma 163
The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients 163
DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION FOR ISHIKAWA TYPE B ADENOCARCINOMA: UNDERTREATMENT OR NOT? 162
Genes involved in gemcitabine activity: pancreas cancer vs primary cell cultures 161
Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. 161
PROGNOSTIC IMPACT OF CONSERVATIVE SURGERY FOR PANCREATIC IPMNS 161
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma 160
Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger 159
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 IDENTIFY PATHOLOGICAL SUBTYPES AND THEIR PROGNOSIS IN AMPULLARY ADENOCARCINOMAS PATIENTS 159
EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE 159
Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2 159
CONSERVATIVE SURGERY FOR PANCREATIC IPMNS: PROGNOSTIC IMPACT ON TUMOR PROGRESSION AND ON QUALITY OF LIFE 159
CHARACTERIZATION OF HUMAN ISLETS IN POLYELECTROLYTE MULTILAYER CAPSULES 158
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer 157
MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. 157
Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study 156
THE ROUTINE USE OF SOMATOSTATIN ANALOGUES AFTER PANCREATODUODENECTOMY: ITS CLINICAL IMPACT BASED ON A CASE-MATCHED COMPARISON ACCORDING TO FISTULA RISK SCORE, ASA AND SURGICAL TECHNIQUE 156
3D IN VITRO MODEL OF PANCREATIC DUCTAL ADENOCARCINOMA: NEW STRATEGY TO STUDY PANCREATIC DUCTAL ADENOCARCINOMA 156
Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing 155
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 154
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. 152
Tuning scaffold pore features to accomplish biomimicry in liver and pancreas 3D tumor models: a study on cancer cell aggregation, migration and morphotype transition 152
Dysregulated insulin secretion is associated with pancreatic β-cell hyperplasia and direct acinar-β-cell trans-differentiation in partially eNOS-deficient mice 150
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 150
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 149
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. 148
. THE ROLE OF ABDOMINAL ULTRASOUND SCAN FOR THE FOLLOW-UP OF PANCREATIC CYSTIC LESIONS: A COST- SAVING AND SAFE ALTERNATIVE TO THE ROUTINE USE OF MRI? 148
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology 147
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds 147
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 146
Treatment strategy for pancreatic IPMNs: prognostic impact of conservative surgery 146
ISHIKAWA TYPE B ADENOCARCINOMA OF THE PANCREATIC HEAD: DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION AN ONCOLOGICALLY ACCEPTABLE OPTION? 144
PANCREATIC CYSTIC LESIONS’ FOLLOW-UP WITH ABDOMINAL ULTRASOUND SCAN: COULD IT PLAY AN ALTERNATIVE ROLE TO THE ROUTINE USE OF MRI? 144
Development of 3D models of pancreatic ductal adenocarcinoma via tissue engineering 143
New platforms for PDAC preclinical studies: 3d tissue engineered models based on primary cancer cells and synthetic scaffolds 141
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 141
NSC631570 affects MMP9, HENT1, and SPARC expression in cell cultures of pancreatic cancer. Can we use it in combination with gemcitabine/nab-paclitaxel? 141
COMPARISON BETWEEN ROBOTIC ASSISTED AND THE “GOLD STANDARD” OPEN APPROACH FOR LEFT SIDE CYSTIC TUMOR OF THE PANCREAS: RESULTS FROM A SINGLE CENTER 139
The occurrence of prion protein in surgically resected pancreatic adenocarcinoma 139
Intra-pancreatic fat mononuclear cell infiltration: A link between visceral fat accumulation and beta-cell failure in human type 2 diabetes? 138
EARLY MONOCENTRIC EXPERIENCE IN EUS-FNA WET-TECHNIQUE FOR PANCREATIC LESIONS 138
HEPATOSTEATOSIS AND ISLET ISOLATION 135
Mononuclear cell infiltration of intra-pancreatic fat and decreased islet beta cell area in human type 2 diabetes 135
Prognostic impact of conservative surgery for pancreatic IPMNs 129
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. 128
APOPTOSIS IN A SERIES OF GEP-NET 127
Silver nanoparticle-coated polyhydroxyalkanoate based electrospun fibers for wound dressing applications 127
PANCREATIC CYSTIC LESIONS IN FOLLOW-UP: COULD ABDOMINAL ULTRASOUND SCAN REPRESENT A SAFE AND COST-SAVING ALTERNATIVE TO MRI? 126
Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology 126
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 125
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 125
Cheilognatopalatoschisi: Analisi morfologica ed istoenzimatica del muscolo orbicolare della bocca 123
LASER MICRODISSECTION (LMD) AND PRIMARY CELL CULTURES IMPROVE PHARMACOGENETIC ANALYSIS IN PANCREATIC ADENOCARCINOMA ALLOWING THE USE OF GENE EXPRESSION LEVELS AND WHO GRADING AS PROGNOSTIC MARKERS 121
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman 121
DOES INTRAPANCREATIC FAT ACCUMULATION INFLUENCE ISLETS FUNCTION AND SURVIVAL IN TYPE 2 DIABETIC PATIENTS? A STUDY WITH ISOLATED PANCREATIC ISLETS 120
IDENTIFICATION OF PATHOLOGICAL AMPULLARY ADENOCARCINOMAS SUBTYPES AND THEIR PROGNOSIS USING THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 120
3D In Vitro Model of Pancreatic Ductal Adenocarcinoma: New Strategy to Study Pancreatic Ductal Carcinoma 120
P53 STATUS AND RESPONSE TO GEMCITABINE BASED THERAPY IN PANCREATIC CARCINOMA PATIENTS 119
ROBOTIC ASSISTED VERSUS OPEN LEFT PANCREATECTOMY FOR CYSTIC TUMORS: A SINGLE CENTER EXPERIENCE 118
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 116
TUMOR VOLUME AND MICROSATELLITE INSTABILITY INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 115
TRANSFECTION OF SIRNA FOR ERK1-2 IN PRIMARY PANCREATIC CANCER CELLS CULTURES BY ELECTROPORATION REDUCE THE CELL GROWTH IN VITRO 114
Totale 21.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/20221.380 18 89 38 81 246 183 45 93 51 57 132 347
2022/20231.766 197 265 147 131 223 213 20 114 297 14 120 25
2023/20247.170 167 163 201 98 243 278 64 51 23 5.645 90 147
2024/20253.651 39 130 40 239 400 427 284 180 381 499 312 720
2025/20264.012 258 446 448 267 477 350 686 188 313 394 132 53
Totale 23.254